| 1Z3J | A: | SOLUTION STRUCTURE OF MMP12 IN THE PRESENCE OF N-ISOBUTYL-N-4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) |
| 2CLT | A:81-252; B:81-252 | CRYSTAL STRUCTURE OF THE ACTIVE FORM (FULL-LENGTH) OF HUMAN FIBROBLAST COLLAGENASE. |
| 2JSD | A: | SOLUTION STRUCTURE OF MMP20 COMPLEXED WITH NNGH |
| 2W0D | A:; B:; C:; D: | DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES. |
| 2Y6C | A: | THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER |
| 2Y6D | A: | THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER |
| 3F15 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (S)-N-(2,3-DIHYDROXYPROPYL)-4-METHOXY-N-(2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE |
| 3F16 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR (R)-N-(3-HYDROXY-1-NITROSO-1-OXOPROPAN-2-YL)-4-METHOXYBENZENESULFONAMIDE |
| 3F17 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-(2-NITROSO-2-OXOETHYL) BIPHENYL-4-SULFONAMIDE |
| 3F18 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR 4-FLUORO-N-(2-HYDROXYETHYL)-N-(2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE |
| 3F19 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR 4-FLUORO-N-(2-NITROSO-2-OXOETHYL)BENZENESULFONAMIDE |
| 3F1A | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-(2-NITROSO-2-OXOETHYL) BENZENESULFONAMIDE |
| 3LK8 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR PARAMETHOXY-SULFONYL-GLYCINE HYDROXAMATE |
| 3LKA | A: | CATALYTIC DOMAIN OF HUMAN MMP-12 COMPLEXED WITH HYDROXAMIC ACID AND PARAMETHOXY-SULFONYL AMIDE |
| 3MA2 | A:; D: | COMPLEX MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE (MT1-MMP) WITH TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) |
| 3NX7 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH THE INHIBITOR N-HYDROXY-2-(N-(2-HYDROXYETHYL)4-METHOXYPHENYLSULFONAMIDO)ACETAMIDE |
| 3TS4 | A: | HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR |
| 3TSK | A: | HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR |
| 3TT4 | A: | HUMAN MMP8 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR |
| 3UVC | A:; B: | MMP12 IN A COMPLEX WITH THE DIMERIC ADDUCT: 5-(5-PHENYLHYDANTOIN)-5-PHENYLHYDANTOIN |
| 3V96 | B: | COMPLEX OF MATRIX METALLOPROTEINASE-10 CATALYTIC DOMAIN (MMP-10CD) WITH TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) |
| 4EFS | A: | HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR |
| 4GQL | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470.1 |
| 4GR0 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470B |
| 4GR3 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470A |
| 4GR8 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470C |
| 4H30 | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR. |
| 4H49 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-12 IN COMPLEX WITH A TWIN INHIBITOR. |
| 4H76 | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A BROAD SPECTRUM HYDROXAMATE INHIBITOR |
| 4H84 | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX WITH A SELECTIVE CARBOXYLATE BASED INHIBITOR. |
| 4I03 | A: | HUMAN MMP12 IN COMPLEX WITH A PEG-LINKED BIFUNCTIONAL L-GLUTAMATE MOTIF INHIBITOR |
| 4ILW | D:; F: | COMPLEX OF MATRIX METALLOPROTEINASE-10 CATALYTIC DOMAIN (MMP-10CD) WITH TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2) |
)
)